Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 10/20 | 0.88 |
| ▸ | AVPR1B | P47901 | 8/20 | 0.88 |
| ▸ | AVPR2 | P30518 | 7/20 | 0.88 |
| ▸ | OXTR | P30559 | 7/20 | 0.88 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.79 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.79 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.79 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ornipressin SCHEMBL1650220 | 1.00 | AVPR1A (0.88) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Ornipressin SCHEMBL4410141 | 0.98 | AVPR1A (0.85) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Lypressin SCHEMBL33287 | 0.98 | OXTR (0.87) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Lypressin SCHEMBL1650587 | 0.98 | OXTR (0.87) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Ornipressin SCHEMBL5200435 | 0.97 | AVPR1A (0.83) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Lypressin SCHEMBL29471105 | 0.97 | OXTR (0.84) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| SCHEMBL24239052 | 0.96 | OXTR (0.82) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Felypressin SCHEMBL1650172 | 0.95 | AVPR1A (0.82) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Felypressin SCHEMBL31138866 | 0.95 | AVPR1A (0.82) | AVPR1AAVPR1BAVPR2OXTRTBXA2R | |
| Felypressin SCHEMBL361197 | 0.95 | AVPR1A (0.82) | AVPR1AAVPR1BAVPR2OXTRTBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4633737-A1 | USES OF AVPR1A AGONISTS | Viage Therapeutics Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| CN-222089382-U | Connection structure of motor and wind wheel | 佛山市南海区绿智电机设备有限公司 | 2024-11-29 | — | — | CN | claimed |
| EP-4452534-A1 | SUPPLY DEVICE, SUPPLY SYSTEM AND SYSTEM | TOX PRESSOTECHNIK GmbH & Co. KG (DE) | 2024-10-30 | — | — | EP | claimed |
| US-20240277624-A1 | NEW FORMULATIONS COMPRISING BIOLOGIC ACTIVE DRUGS | NANEXA AB (SE) | 2024-08-22 | — | — | US | claimed |
| CN-118510615-A | Feeding device, feeding system and system | TOX机械工程股份有限公司 | 2024-08-16 | — | — | CN | claimed |
| EP-3815476-B1 | ELECTRONICS MODULE WITH PLUG CONNECTION | BOSCH GMBH ROBERT (DE) | 2024-08-07 | — | — | EP | claimed |
| CN-114467242-B | Rotary electric machine | 三菱电机株式会社 | 2024-07-09 | — | — | CN | claimed |
| CN-118232064-A | Electronic module and contact assembly | 罗伯特·博世有限公司 | 2024-06-21 | — | — | CN | claimed |
| WO-2024130011-A1 | USES OF AVPR1A AGONISTS | VIAGE THERAPEUTICS INC. (US) | 2024-06-20 | — | — | WO | claimed |
| WO-2024126382-A1 | CONTROL DEVICE AND METHOD FOR ASSEMBLING THE CONTROL DEVICE | ROBERT BOSCH GMBH (DE) | 2024-06-20 | — | — | WO | claimed |
| WO-2003063780-A2 | THERAPEUTIC COMPOSITION FOR TREATMENT OF CANCER BY ARGININE DEPLETION | CANCER TREATMENTS INTERNATIONAL (CH) | 2003-08-07 | — | — | WO | claimed |
| WO-2003035030-A1 | KIT FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION | PARI GMBH (DE) | 2003-05-01 | — | — | WO | claimed |
| EP-1227856-A1 | INHALATION NEBULIZER | PARI GmbH Spezialisten für effektive Inhalation (DE) | 2002-08-07 | — | — | EP | claimed |
| WO-2001034232-A9 | INHALATION NEBULIZER | PARI GMBH (DE) | 2002-08-01 | — | — | WO | claimed |
| WO-2001034232-A1 | INHALATION NEBULIZER | Pari GmbH Spezialisten für effektive Inhalation (DE) | 2001-05-17 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1062229-A1 | PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS | Zealand Pharmaceuticals A/S (DK) | 2000-12-27 | — | — | EP | claimed |
| WO-1999046283-A9 | PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS | ZEALAND PHARMACEUTICALS A S (DK) | 1999-11-18 | — | — | WO | claimed |
| WO-1999046283-A1 | PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS | ZEALAND PHARMACEUTICALS A/S (DK) | 1999-09-16 | — | — | WO | claimed |
| WO-1995005078-A1 | SUBMICRON EMULSIONS FOR DELIVERY OF PEPTIDES | PHARMOS CORPORATION (US) | 1995-02-23 | — | — | WO | claimed |